Cigniti Technologies provides critical medical equipment to the Gynecology Facility at the Government MNJ Institute of Oncology, Regional Cancer, Hyderabad, India.

Cigniti Technologies

March 2023, Mumbai: As part of its CSR initiative, Project Cignificance, Cigniti Technologies, the world’s leading AI and IP-led Digital Assurance and Digital Engineering services company, extended its support to the Government MNJ Institute of Oncology, Regional Cancer in Hyderabad, India. Cigniti provided crucial healthcare and essential medical equipment for a gynecology unit supporting women cancer patients from marginalized communities.

Cigniti Technologies has always been at the forefront of supporting healthcare initiatives. This latest contribution reflects our commitment to supporting this facility with essential medical equipment like ICU beds, Ventilators, Multi-Channel Monitors, Infusion Pumps, Ultrasound Portable, Colposcope, air conditioners for the room, and many more. This equipment will enable them to offer more advanced care and medical attention to the patients.

The facility was inaugurated by Mr. Raghu Krovvidy, CDO at Cigniti Technologies in the presence of Mr. Sairam Vedam, CMO at Cigniti Technologies, and Mr. Midhun Pingili, Sr. Director of Marketing at Cigniti Technologies. Mr. Mayur Patnala, Founder and CEO of Nirmaan Organization, and Dr. Jayalatha, Director of MNJ Institute of Oncology and Regional Cancer Hospital, graced the occasion at the hospital.

By collaborating with Nirmaan Organization, Cigniti aims to reduce the stress on the existing public healthcare system caused by the increase in gynecology-related cases, such as delivery cases in Mother and Child hospitals and tertiary hospitals. This assistance will deliver better healthcare, minimize gynecology referrals to private/tertiary hospitals, and offer a green channel for women on a walk-in basis to decrease the waiting period. With this support, the facility will be able to provide medical attention to at least 1,000 marginalized patients annually.

Leave a Reply

Your email address will not be published. Required fields are marked *